Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025

Lilly to acquire biotech developing pain drugs

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. ly-to-acquire-biotech-developing-pain-drugs.html
  Print publication without navigation Published in Science and Technology on by STAT
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
And more can't-miss biotech news brought to you by The Readout.
The article from STAT News dated May 28, 2025, discusses several key developments in the biotech industry. Spero Therapeutics announced positive results from a Phase 3 trial of tebipenem HBr, an oral antibiotic for complicated urinary tract infections. GSK reported successful outcomes in a Phase 2 trial for a new shingles vaccine, showing improved efficacy over their current product. Eli Lilly shared promising data from a Phase 2 study of a new Alzheimer's drug, suggesting potential disease-modifying effects. Rocket Pharmaceuticals received FDA approval for a gene therapy targeting a rare genetic disorder. Novavax provided updated guidance on its Covid-19 vaccine, anticipating increased demand due to new variants. These updates highlight significant progress and ongoing innovation in the biotech sector.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/05/28/biotech-news-spero-gsk-eli-lilly-rocket-novavax-covid-vaccine-guidance-the-readout/ ]